News

GI Supply Welcomes Donna Rodriguez as Chief Financial Officer
September 10, 2018 | Mechanicsburg, PA

GI Supply is proud to announce the addition of Donna Rodriguez as Chief Financial Officer beginning September 10th, 2018. Donna is a CPA and started her career in auditing at the public accounting firm of Ernst & Young. From there Donna embarked on a 20+ year career at McDonald’s, starting off in accounting roles for the restaurants, real estate and benefit plans. She later moved into increasingly senior leadership roles in Corporate Development, Strategy, and Investor Relations. Over the last several years Donna was the Sr. VP of Finance for East Balt Bakeries, a large global food service company.

Read Full Story

Donna brings a fantastic background and many unique perspectives to our efforts at GI Supply. She has a rare combination of intellect, energy, personality, and financial insight, and we’re thrilled she’ll be joining us. Donna will be based out of GI Supply’s Chicago office.

Meet the rest of our Leadership Team.

G-1490-01


GI Supply Opens New Dedicated Manufacturing Facility
August 20, 2018 | Mechanicsburg, PA

GI Supply is excited to announce the opening of our new dedicated manufacturing facility just outside Harrisburg, Pennsylvania (5069 Ritter Road, Suite 104, Mechanicsburg, PA 17055). This new facility is another important step in the transformation of GI Supply towards a larger, more diversified, and more technologically capable medical device company.

Read Full Story

“Our new Ritter Road facility marks the first time GI Supply will begin internal manufacturing of our leading product lines. By doing so, we will deliver even higher levels of product quality and customer responsiveness,” commented Luke Johnson, CEO of GI Supply. “The facility also has plenty of space to accommodate the growth we anticipate from our near-term R&D pipeline of innovative devices that will enable gastroenterologists to perform more advanced procedures safely and efficiently. We are really proud to continue to manufacture our products in the U.S.A., and to continue to invest in the Harrisburg, PA and surrounding community.”

G-1475-01


Further Global Expansion of Spot® Ex – Now In Australia & New Zealand
August 9, 2018 | Camp Hill, PA

As part of the continuing global launch of its Spot® Ex Endoscopic tattoo, GI Supply Inc. announced that it is now available in two additional markets: Australia & New Zealand.

Spot® Ex is used to endoscopically mark cancerous tissue, suspicious lesions and polyps for easier future identification at a future colonoscopy or surgery. It is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement new guidelines.
Read Full Story

Australia & New Zealand represent a combined total of 20,000 cases of colorectal cancer every year, and it is the second most common cancer in the region. Through its local distributors, GI Supply is excited to be able to offer gastroenterologists in both countries the opportunity to use Spot Ex on their patients:

Australia
Endomed Pty. Ltd.
“Endomed is excited to announce that SPOT EX is now available in Australia. This advancement will support clinicians by allowing longer term follow up as well as providing better care for patients.”
– Deborah Jew

New Zealand
Obex Medical Ltd.
“Obex Medical are delighted to launch Spot Ex into the New Zealand market. The expanded indications and new features of Spot Ex will assist clinicians in being able to provide the best diagnosis and therapy to ensure the best outcomes for our patients.”
– Jackie Shaw


If you would like to find out more about Spot Ex and how it can help your clinical practice, then please contact your local distributor, or contact us directly via info@gi-supply.com.

Learn more about Spot Ex in these countries at www.spotextattoo.eu

Orders can be placed by phone at (800) 451-5797 or by Email at orders@gi-supply.com

 

CONTACT INFORMATION

Media

Contact: Dan McCoy, Vice President, Marketing

Phone: +1-312-608-1745

Email: d.mccoy@gi-supply.com

G-1461-01


GI Supply Unveils Enhanced RenovaRP® Paracentesis Management System
June 12, 2018 | Camp Hill, PA

RenovaRP Portable Pump and Redesigned Renova Procedure Kit
Improve All Aspects of Large-Volume Paracentesis Procedures

GI Supply, Inc. unveiled today an enhanced edition of the RenovaRP® Paracentesis Management System featuring a new and improved preassembled, single patient procedure kit designed to meet the specific requests of clinicians. The RenovaRP Paracentesis Management System expedites paracentesis procedures allowing medical professionals to treat patients safely, quickly, and cost-effectively. Renova removes ascites fluid by gentle, continuous flow, often in less than 30 minutes, and without the need for evacuated bottles or canisters.
Read Full Story

“Renova has revolutionized the treatment of ascites for our patients. They love it because it decreases the time that they are in the hospital–in fact our patients demand we use Renova,” said Dr. Rajeev Suri, Vice Chair Clinical Operations, UT Health Science San Antonio (UTHSCSA), Radiology. “The physicians prefer it because it’s fast to set up and easy to use. The nurses love it because they can closely monitor their patients while increasing the number of people they can see. Our entire hospital benefits because with Renova, we can care for more patients, and perform more procedures in a safer format.”

“Managing ascites can be a long and difficult process for patients who may have to undergo hours of paracentesis, sometimes even multiple times a week,” said Luke Johnson, CEO of GI Supply. “The RenovaRP Paracentesis Management System, including our new procedural kit that was designed working hand-in-hand with medical professionals, improves all aspects of the paracentesis procedure.”

Enhancing Patient Safety and Satisfaction
Traditional paracentesis techniques rely on evacuated containers or glass bottles to drain ascitic fluid from the abdomen, which can take a substantial amount of time and require careful monitoring. The RenovaRP Paracentesis Management System, on the other hand, is a closed and clean system that evacuates ascitic fluid directly into fully-sealed bags in one continuous process via a peristaltic pump. The System improves patient satisfaction and comfort through its quick, safe fluid removal and the operator’s ability to finely control flow rates and adjust them to a patient’s needs.

A Faster, Easier, Safer Process for Staff
Unlike the wall suction approach to paracentesis, the RenovaRP Paracentesis Management System is portable, allowing it to be used in a variety of clinical settings. Renova’s fully-sealed collection bag system helps expedite procedures by eliminating down time and ensures safe fluid handling throughout. Additionally, the newly redesigned pre-assembled, single-use procedure kits enable fast set up, saving clinicians and patients valuable time.

More Cost-Effective
RenovaRP Paracentesis Management System is a more cost-effective way to manage ascites because it can shorten procedure times compared to traditional drainage methods. In turn, shorter procedures save time and labor. Additionally, because it uses plastic bags versus glass or plastic bottles, it saves storage space, reduces the risks of breaks and spills, and eliminates the need for solidifiers for disposal.


About GI Supply
GI Supply, Inc., a private company based in Camp Hill, PA, was founded nearly 30 years ago by Dr. Frank Jackson, a gastroenterologist and entrepreneur, to help solve many of the clinical challenges he faced in daily practice. Today, GI Supply products are used daily around the world by gastroenterologists and colorectal surgeons in more than 40 countries. We’d love for you to join them. Visit www.gi-supply.com for more information.

Orders can be placed by phone at (800) 451-5797 or by Email at orders@gi-supply.com

 

CONTACT INFORMATION

Media

Contact: Dan McCoy, Vice President, Marketing

Phone: +1-312-608-1745

Email: d.mccoy@gi-supply.com

G-1437-01


Spot® Ex Endoscopic Tattoo Receives CE Mark – Launches in Europe
May 7, 2018 | London, UK

GI Supply, Inc. announced today that its Spot® Ex Endoscopic Tattoo received CE Mark and is now available in Europe. Spot Ex® is used to endoscopically mark cancerous tissue, suspicious lesions and polyps for easier future identification at follow-up colonoscopy procedure or surgery. It is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement the new ESGE guidelines.
Read Full Story

“Advances in screening and therapy are helping reduce colon cancer death rates across Europe. Polypectomy and EMR are now common skills for gastroenterologists, and allow patients to get cancer cured without the need for traditional surgery,” said Professor Cesare Hassan, Head of Endoscopy Unit at Nuovo Regina Margherita Hospital in Rome. “The new ESGE guidelines formulated by the most worldwide recognized experts recommend long-term follow-up of patients who had these procedures to detect and treat recurrences in order to reduce the risk of interval cancer.” Professor Hassan further added, “I’m very happy to have Spot Ex because it’s the only tattoo indicated for long-term clinical surveillance.”

The new ESGE guidelines recommend tattooing all lesions that need to be followed-up at future colonoscopy or surgery (Ferlitsch 2017). Spot Ex® is the only endoscopic tattoo with a long-term clinical surveillance indication.

The new Spot Ex formulation is also much darker than the current Spot product, making the tattoo easier-to-find and helping endoscopists and surgeons manage time and productivity pressures. Two new clinical studies were conducted to verify 100% visibility of Spot at follow-up procedures up to 11 years later. (Cano 2017 and Jackson 2017).

“Our mission at GI Supply is to help more GI physicians do more advanced endoscopic procedures safely and efficiently, and Spot Ex is a great next step in meeting those needs,” said Luke Johnson, CEO of GI Supply. “We’re happy to expand the availability of Spot Ex into Europe and provide clinicians with the next step in the fight against colon cancer.”

About GI Supply: GI Supply, Inc., a private company based in Camp Hill, PA, was founded nearly 30 years ago by Dr. Frank Jackson, a gastroenterologist and entrepreneur, to help solve many of the clinical challenges he faced in daily practice. Today, GI Supply products are used around the world daily by gastroenterologists and colorectal surgeons in more than 50 countries.

Learn more about Spot Ex at http://www.spotextattoo.eu

Spot Ex European Press Releases:
English
French
German
Italian
Spanish
Dutch

Find a European Distributor of Spot Ex

 

CONTACT INFORMATION

Media

Contact: Caroline Abrego, European Marketing Manager

Phone: +44 7831482380

Email: c.abrego@gi-supply.com

G-1430-01


GI Supply Introduces Spot® Ex Endoscopic Tattoo
January 15, 2018 | Camp Hill, PA

GI Supply, Inc. announced today the U.S. launch of the Spot® Ex Endoscopic Tattoo, which helps gastroenterologists and surgeons take the next step in the fight against colon cancer. Spot Ex is now indicated for clinical surveillance in addition to surgical localization. Leading societies recommend tattooing of malignant lesions, post-polypectomy sites, and difficult-to-detect polyps to enable future identification at follow-up colonoscopy or surgery.1
Read Full Story

Recently published national data highlighted that colon cancer incidence and mortality rates are rising in younger patients.2,3 Additionally, new clinical guidelines have been released from the European Society Gastrointestinal Endoscopy (ESGE) that recommend tattooing all lesions that need to be followed-up at future colonoscopy or surgery.1

Spot Ex helps clinicians combat these trends and implement the guidelines by offering expanded indications that include long-term clinical surveillance. The new Spot Ex Endoscopic Tattoo provides a permanent mark, enabling a lifetime of patient care follow-up. Spot Ex is also 50% darker than the current Spot product, making the tattoo easier-to-find4 and helping endoscopists and surgeons manage time and productivity pressures.

“As a therapeutic endoscopist at Northwestern Memorial Hospital, I am often referred complex polyp removal cases. In those scenarios, it is very beneficial to have the polyp tattooed for easy identification,” said Dr. Sri Komanduri, Gastroenterologist. “In addition, post-resection I typically follow-up with the patient within six months to ensure there is no adenoma recurrence, and a tattoo helps with that surveillance. The new Spot Ex tattoo will help me monitor that patient as long as needed.”

“In my practice at San Antonio Gastroenterology Associates we have seen a steady increase in young patients being diagnosed with colon cancer. Fortunately, earlier diagnosis and new endoscopic therapies we offer are working,” said Dr. Antonio Serna, Gastroenterologist. “But these patients need to come back for many years of surveillance. Spot Ex gives me a way to feel confident in my assessment of cancer remission or recurrence.”

“We’re excited to aid in the fight against colon cancer and advance the science of endoscopic tattooing with a permanent and cost-effective solution for gastroenterologists and surgeons. Our mission at GI Supply is to help more GI physicians do more advanced endoscopic procedures safely and efficiently, and Spot Ex is a great next step in meeting those needs,” said Luke Johnson, CEO of GI Supply.

References
1. Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): ESGE Clinical Guideline. 2017.

Read the guidelines at www.gi-supply.com/esge

2. Siegel R. et al. JNCI J Natl Cancer Inst. 2017
3. Siegel R. et al. JAMA. 2017
4. Lee. P., Finding Endoscopic Tattoos: The Impact of Contrast. GI Supply. 2018.

About GI Supply: GI Supply, Inc., a private company based in Camp Hill, PA, was founded nearly 30 years ago by Dr. Frank Jackson, a gastroenterologist and entrepreneur, to help solve many of the clinical challenges he faced in daily practice. Today, GI Supply products are used around the world daily by gastroenterologists and colorectal surgeons in more than 40 countries. We’d love for you to join them. Visit www.gi-supply.com for more information.

Orders can be placed by phone at (800) 451-5797 or by Email at orders@gi-supply.com

CONTACT INFORMATION

Media

Contact: Dan McCoy, Vice President, Marketing

Phone: +1-312-608-1745

Email: d.mccoy@gi-supply.com

G-1384-01


An Evidence-based Protocol for Endoscopic Tattoo
November 13, 2017 | Camp Hill, PA

Spot® Endoscopic Marker is clinically proven and society recommended as the standard of care for clinical surveillance and surgical localization.  Despite calls for standardization in clinical literature as recent as the May 2017 Journal of the Royal Society of Medicine article “Endoscopic Tattoo: the importance and need for standardized guidelines and protocol”, no such protocol exists in scientific literature.
Read Full Story

To help in the fight against colon cancer, GI Supply has developed an evidence-based protocol that will help Endoscopists decide whether to tattoo a lesion for further surveillance. This first of it’s kind evidence-based protocol is built based on the recently released European Society for Gastrointestinal Endoscopy (ESGE) practice guidelines for EMR and polypectomy, which provides the most comprehensive recommendations to date. The protocol is laid out as an easy to implement decision-tree Endoscopists can follow in daily practice.

Click below to download the protocol.

Download Now

G-1357-01


GI Supply Partners with Global Medicine to Support Russian Gastroenterologists
October 20, 2017 | St Petersburg, Russia

As part of GI Supply’s continued global expansion, GI Supply has appointed Global Medicine LLC as their partner in the Russian Federation.
Read Full Story

With a population of over 143m and more than 60,000 cases of colorectal cancer every year, there is a clear need to support Russian gastroenterologists with products such as the Spot Endoscopic Marker.

Veronika Akhmadieva, MD of Global Medicine, said “Our company is pleased to present a product as innovative as Spot to the Russian market! We look forward to working with GI Supply to help surgeons fight colorectal cancer with Spot, by improving the accuracy of lesion marking in the digestive tract, and helping to provide better patient outcomes.”

We look forward to working with Veronika and her team as GI Supply enters this exciting market.

Global Medicine LLC,
Business Centre Zolotaya Shpalernaya,
54 Shpalernaya Street,
St. Petersburg,
Russia Federation

Phone: +7(812)401-42-43
Web: www.globalmed.pro


GI Supply Partners with Boston Medical to Bring Spot® to Croatia
September 7, 2017 | Camp Hill, PA

Spot® Endoscopic Marker is now available in Croatia from Boston Medical!
Read Full Story

GI Supply and Boston Medical are helping Croatian gastroenterologists Win The Fight Against Colon Cancer by partnering to offer Spot Endoscopic Marker in this growing market. With more than 25 published clinical studies, and new guidelines from ESGE calling for tattooing all lesions gastroenterologists need to see at future colonoscopy or surgery, Spot will enable clinicians to monitor lesions post-polypectomy and help surgical partners localize lesions faster.

BOSTON MEDICAL d.o.o.
Lašcinska cesta 14
Zagreb, 10 000
Phone: +385 1 4002 100
Fax: +385 1 4002 105
Web: bostonmedical.hr


2017 Edition of Meducate® Patient Education Brochures Now Available
July 10, 2017 | Camp Hill, PA

Meducate® Patient Education Brochures are now all available in their 2017 edition in English and Spanish.
Read Full Story

GI Supply offers the widest variety of GI focused patient education materials on procedural and disease topics. All 40 brochures have been updated to reflect current practice and medications. Written and reviewed by a practicing gastroenterologist, you can be sure your patients will have the information they need after they leave your office.

Learn more about Meducate Patient Education.


GI Supply Opens European Office To Support Global Distributors and Enter New Markets
June 5, 2017 | London, UK

Focusing on global growth, GI Supply hired its first full-time staff in Europe to support its 40+ global distributors.
Read Full Story

Caroline Abrego (c.abrego@gi-supply.com) joins GI Supply as European Marketing Manager, and Simon Humphrey-Adam (s.humphrey-adam@gi-supply.com) joins as Global Growth Leader, entering new markets.

Find more information about becoming a GI Supply distributor.


GI Supply Welcomes Hank Struik To Board of Directors
April 6, 2017 | Camp Hill, PA

GI Supply welcomed Hank Struik to the board of directors at its April 2017 Shareholder Meeting.
Read Full Story

Mr. Struik, who is currently Chairman and CEO of Northfield Medical, brings with him financial, operational, and leadership expertise from past roles at Cardinal Health, Labsco, and as an operating partner at Frazier Healthcare Partners.

Mr. Struik fills Mr. William Alexander’s board seat. GI Supply is tremendously grateful for Mr. Alexander’s leadership and guidance to the company over many years and wish him well as he continues lecturing at The Wharton School of Business at the University of Pennsylvania.


2017 ESGE Guidelines on Colorectal Polypectomy and EMR Call For Tattooing All Lesions
February, 2017 | Lyon, France

European Society of Gastrointestinal Endoscopy released 2017 practice management guidelines for colorectal polypectomy and endoscopic mucosal resection (EMR) which call for tattooing all lesions for future colonoscopy or surgery.
Read Full Story

New guidelines from the European Society of Gastrointestinal Endoscopy (ESGE) detail the latest thinking in colorectal polypectomy and endoscopic mucosal resection (EMR) based on published clinical evidence. Among their recommendations on when and how to prepare and conduct therapeutic colonoscopy procedures includes specific guidance on when and how to tattoo as a standard of care.

“Colonoscopic tattooing is performed to enable future identification, at colonoscopy or surgery, of malignant lesions (proven or suspected), polypectomy, EMR, or ESD sites, difficult-to-detect polyps, or dysplastic areas. All such lesions, other than those definitely located in the cecum, adjacent to the ileocecal valve, or in the low rectum, should be tattooed.”1

Spot® Endoscopic Marker has more than 25 published clinical studies showing the value of post-polypectomy clinical surveillance for future identification of lesions and surgical localization. These guidelines provide a clear summary of these data for Endoscopists and guidance on when to tattoo; All lesions that will need future colonoscopy or surgery should be tattooed.

Read the 2017 ESGE Guidelines Here

Learn more about Spot Endoscopic Marker

1. Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): ESGE Clinical Guideline. 2017